Clinical trial
A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy
NCT04058704
Study timeline
Study start (actual)2018-07-20Date precision: day
Registry last updated2019-08-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Brain Metastasesunresolved
Interventions
IcotinibDRUG
SRS/WBRT/HA-WBRT/SMARTRADIATION
Sponsors & collaborators
Betta Pharmaceuticals Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04058704 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.